Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,913 | 53,137 | 23,201 | 27,892 | 26,562 |
| Marketable Securities | 1,245 | 0 | 22,520 | N/A | 4,993 |
| Receivables | 83,008 | 42,221 | 35,074 | 18,976 | 11,878 |
| Inventories | 11,544 | 18,216 | 16,000 | 11,350 | 9,275 |
| Other current assets | 8,030 | 8,140 | 8,235 | 10,442 | 505 |
| TOTAL | $174,272 | $126,591 | $108,446 | $71,308 | $55,536 |
| Non-Current Assets | |||||
| PPE Net | 26,015 | 24,020 | 15,961 | 14,895 | 16,158 |
| Intangibles | 18,974 | 8,788 | 1,573 | 1,926 | 2,496 |
| Other Non-Current Assets | 38,244 | 53,132 | 6,771 | 148 | 148 |
| TOTAL | $83,233 | $85,940 | $24,305 | $16,969 | $18,802 |
| Total Assets | $257,505 | $212,531 | $132,751 | $88,277 | $74,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,500 | 16,230 | N/A | 3,043 | N/A |
| Accounts payable and accrued liabilities | 17,056 | 16,194 | 12,905 | 11,135 | 5,957 |
| Accrued Expenses | 35,043 | 25,635 | 16,523 | 11,997 | 6,982 |
| TOTAL | $58,930 | $63,205 | $32,415 | $27,193 | $15,733 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,241 | 24,669 | 40,395 | 22,083 | 24,858 |
| Deferred Revenues | 4,427 | 3,943 | 1,738 | 1,018 | 2,794 |
| Other Non-Current Liabilities | 4,576 | 5,542 | 5,441 | 0 | 0 |
| TOTAL | $22,817 | $30,211 | $45,836 | $22,083 | $25,058 |
| Total Liabilities | $81,747 | $93,416 | $78,251 | $49,276 | $40,791 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,106 | 168,161 | 165,560 | 160,532 | 156,789 |
| Common Shares | 1,701 | 1,668 | 1,652 | 1,597 | 1,567 |
| Retained earnings | -176,337 | -222,626 | -278,827 | -276,800 | -270,285 |
| Other shareholders' equity | -685 | -683 | -702 | -703 | -700 |
| TOTAL | $175,758 | $119,115 | $54,500 | $39,001 | $33,547 |
| Total Liabilities And Equity | $257,505 | $212,531 | $132,751 | $88,277 | $74,338 |